Schaper Benz & Wise Investment Counsel’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.8M Sell
89,831
-745
-0.8% -$174K 1.52% 19
2026
Q1
$22.1M Sell
90,576
-2,409
-3% -$561K 1.69% 17
2025
Q4
$19.2M Sell
92,985
-2,435
-3% -$482K 1.39% 27
2025
Q3
$17.7M Sell
95,420
-893
-0.9% -$153K 1.32% 29
2025
Q2
$14.7M Sell
96,313
-249
-0.3% -$38.3K 1.13% 34
2025
Q1
$16M Sell
96,562
-265
-0.3% -$41.5K 1.3% 31
2024
Q4
$14M Sell
96,827
-656
-0.7% -$102K 1.12% 35
2024
Q3
$15.8M Buy
97,483
+1,768
+2% +$282K 1.26% 34
2024
Q2
$14M Sell
95,715
-496
-0.5% -$73.8K 1.21% 33
2024
Q1
$15.2M Buy
96,211
+4,023
+4% +$640K 1.27% 33
2023
Q4
$14.4M Buy
92,188
+181
+0.2% +$27.8K 1.31% 33
2023
Q3
$14.3M Sell
92,007
-1,129
-1% -$186K 1.41% 32
2023
Q2
$15.4M Buy
93,136
+340
+0.4% +$54.9K 1.48% 30
2023
Q1
$14.4M Sell
92,796
-1,653
-2% -$267K 1.46% 29
2022
Q4
$16.7M Sell
94,449
-4,255
-4% -$735K 1.77% 20
2022
Q3
$16.1M Sell
98,704
-2,714
-3% -$459K 1.87% 17
2022
Q2
$18M Sell
101,418
-9,131
-8% -$1.63M 1.85% 16
2022
Q1
$19.6M Sell
110,549
-3,338
-3% -$568K 1.69% 19
2021
Q4
$19.5M Sell
113,887
-185
-0.2% -$30.3K 1.57% 26
2021
Q3
$18.4M Sell
114,072
-21
-0% -$3.58K 1.65% 24
2021
Q2
$18.8M Sell
114,093
-63
-0.1% -$10.4K 1.69% 21
2021
Q1
$18.8M Buy
114,156
+1,379
+1% +$223K 1.83% 18
2020
Q4
$17.7M Sell
112,777
-539
-0.5% -$79.5K 1.84% 17
2020
Q3
$16.9M Buy
113,316
+234
+0.2% +$34.6K 1.96% 16
2020
Q2
$15.9M Sell
113,082
-3,430
-3% -$500K 1.97% 16
2020
Q1
$15.3M Sell
116,512
-75
-0.1% -$10.6K 2.22% 10
2019
Q4
$17M Sell
116,587
-146
-0.1% -$19.8K 1.99% 15
2019
Q3
$15.1M Buy
116,733
+1,424
+1% +$188K 1.88% 20
2019
Q2
$16.1M Sell
115,309
-1,435
-1% -$199K 2.03% 15
2019
Q1
$16.3M Buy
116,744
+623
+0.5% +$83.5K 2.12% 14
2018
Q4
$15M Sell
116,121
-555
-0.5% -$77.4K 2.24% 13
2018
Q3
$16.1M Buy
116,676
+509
+0.4% +$67.6K 2.16% 15
2018
Q2
$14.1M Buy
116,167
+4,003
+4% +$499K 2.02% 17
2018
Q1
$14.4M Sell
112,164
-330
-0.3% -$44.6K 2.13% 13
2017
Q4
$15.7M Sell
112,494
-1,133
-1% -$158K 2.29% 11
2017
Q3
$14.8M Sell
113,627
-1,084
-0.9% -$144K 2.29% 10
2017
Q2
$15.2M Buy
114,711
+30
+0% +$3.83K 2.44% 10
2017
Q1
$14.3M Buy
114,681
+544
+0.5% +$65K 2.43% 10
2016
Q4
$13.2M Sell
114,137
-2,078
-2% -$240K 2.33% 10
2016
Q3
$13.7M Buy
116,215
+55
+0% +$6.67K 2.41% 10
2016
Q2
$14.1M Sell
116,160
-530
-0.5% -$60.2K 2.54% 8
2016
Q1
$12.6M Buy
116,690
+600
+0.5% +$62.1K 2.37% 10
2015
Q4
$11.9M Buy
116,090
+491
+0.4% +$49.4K 2.35% 11
2015
Q3
$10.8M Buy
115,599
+690
+0.6% +$66.7K 2.19% 17
2015
Q2
$11.2M Sell
114,909
-465
-0.4% -$46.6K 2.2% 16
2015
Q1
$11.6M Buy
115,374
+2,074
+2% +$211K 2.29% 15
2014
Q4
$11.8M Sell
113,300
-1,997
-2% -$210K 2.37% 14
2014
Q3
$12.3M Buy
115,297
+2,445
+2% +$254K 2.58% 11
2014
Q2
$11.8M Sell
112,852
-1,027
-0.9% -$104K 2.43% 14
2014
Q1
$11.2M Buy
113,879
+1,410
+1% +$131K 2.43% 12
2013
Q4
$10.3M Sell
112,469
-1,045
-0.9% -$96.3K 2.29% 16
2013
Q3
$9.84M Buy
113,514
+2,600
+2% +$233K 2.28% 15
2013
Q2
$9.52M Buy
+110,914
New +$9.41M 2.35% 13

Other funds holding JNJ

Schaper Benz & Wise Investment Counsel's JNJ Position: Q2 2026 in Review

Schaper Benz & Wise Investment Counsel reduced its Johnson & Johnson (JNJ) stake by 0.82% in Q2 2026, selling an estimated $174K and leaving 89,831 shares worth $22.8M. The position accounts for 1.52% of the portfolio, ranked #19.

Schaper Benz & Wise Investment Counsel first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Schaper Benz & Wise Investment Counsel held 89,831 shares of Johnson & Johnson worth $22.8M as of Q2 2026.
  • Schaper Benz & Wise Investment Counsel sold 745 Johnson & Johnson shares in Q2 2026, an estimated $174K.
  • Johnson & Johnson made up 1.52% of Schaper Benz & Wise Investment Counsel's portfolio in Q2 2026, its #19 holding.
  • Schaper Benz & Wise Investment Counsel first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Schaper Benz & Wise Investment Counsel's 13F filing for Q2 2026, filed 21 Jul 2026.